首页> 外文OA文献 >In Frail Elderly Patients, Low-Dose Gemcitabine over 6-Hour Infusion Is Equally Effective and Less Toxic Than the Standard Gemcitabine Protocol for Advanced Pancreatic Adenocarcinoma: A Randomized Phase II Trial

【2h】

In Frail Elderly Patients, Low-Dose Gemcitabine over 6-Hour Infusion Is Equally Effective and Less Toxic Than the Standard Gemcitabine Protocol for Advanced Pancreatic Adenocarcinoma: A Randomized Phase II Trial

机译：在勒克老年患者中，低剂量吉西滨过度输注超过6小时的输注同等效果和毒性少于胰腺癌腺癌的标准吉西他滨协议：随机期II试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Salah Mabrouk Khallaf; Elsayed Mostafa Ali; Ahmed M. Maklad; Mohamed Medhat Samir; Anwar Tawfik Amin; Muhammad Abbas El-Masry; Mona M. Sayed; Dalia Osama;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. In Frail Elderly Patients, Low-Dose Gemcitabine over 6-Hour Infusion Is Equally Effective and Less Toxic Than the Standard Gemcitabine Protocol for Advanced Pancreatic Adenocarcinoma: A Randomized Phase II Trial [J] . Salah Mabrouk Khallaf, Elsayed Mostafa Ali, Ahmed M. Maklad, Journal of Cancer Therapy . 2020,第3期

机译：在勒克老年患者中，低剂量吉西滨过度输注超过6小时的输注同等效果和毒性少于胰腺癌腺癌的标准吉西他滨协议：随机期II试验
2. In Frail Elderly Patients, Low-Dose Gemcitabine over 6-Hour Infusion Is Equally Effective and Less Toxic Than the Standard Gemcitabine Protocol for Advanced Pancreatic Adenocarcinoma: A Randomized Phase II Trial [J] . Salah Mabrouk Khallaf, Elsayed Mostafa Ali, Ahmed M. Maklad, 癌症治疗（英文） . 2020,第003期

机译：在年老体弱的患者中，低剂量的吉西他滨经6小时输注同等有效，且毒性低于晚期胰腺腺癌的标准吉西他滨方案：II期随机试验
3. Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: A randomized phase II trial - An update [J] . HaggagR., FaragK., Abu-TalebF., Medical oncology . 2014,第1期

机译：低剂量吉西他滨输注与标准剂量吉西他滨输注及顺铂治疗晚期膀胱癌：一项随机的II期临床试验-最新动态
4. Phase III Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group [O] . Elizabeth Poplin, Yang Feng, Jordan Berlin, -1

机译：吉西他滨和奥沙利铂与吉西他滨（固定剂量率输注）与吉西他滨（30分钟输注）比较在胰腺癌E6201患者中的随机对照试验：东方合作肿瘤小组的一项试验
5. Phase III, Randomized Study of Gemcitabine and Oxaliplatin Versus Gemcitabine (fixed-dose rate infusion) Compared With Gemcitabine (30-minute infusion) in Patients With Pancreatic Carcinoma E6201: A Trial of the Eastern Cooperative Oncology Group [O] . Poplin, Elizabeth, Feng, Yang, Berlin, Jordan, 2009

机译：吉西他滨和奥沙利铂与吉西他滨（固定剂量率输注）与吉西他滨（30分钟输注）比较在胰腺癌E6201患者中的随机对照试验：东方合作肿瘤小组的一项试验

In Frail Elderly Patients, Low-Dose Gemcitabine over 6-Hour Infusion Is Equally Effective and Less Toxic Than the Standard Gemcitabine Protocol for Advanced Pancreatic Adenocarcinoma: A Randomized Phase II Trial

著录项

引文网络

相似文献

相关主题

期刊订阅